Position in PHAT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$615,927
-$248,295 QoQ
Shares Held
55,439
+6.4% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. PHAT ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $615,927 | 55,439 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $864,222 | 52,093 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $726,362 | 61,713 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $619,101 | 64,557 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $355,753 | 56,739 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $454,460 | 55,968 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $919,512 | 50,858 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $568,333 | 55,178 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $500,233 | 47,103 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $442,823 | 48,502 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $586,288 | 56,537 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $718,935 | 50,205 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $233,913 | 32,761 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $344,813 | 30,732 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $320,511 | 28,927 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $224,917 | 26,649 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $271,764 | 19,968 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $338,461 | 17,207 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $560,273 | 17,454 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $556,426 | 16,438 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $427,808 | 11,390 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $405,284 | 12,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $400,436 | 10,920 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $420,918 | 12,790 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $294,941 | 11,423 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||